Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ikaros gene expression and leukemia.

Cécile Tonnelle1, Boris Calmels, Christine Maroc

  • 1Centre de Thérapie Cellulaire et Génique, Institut Paoli-Calmettes, Centre Régional de Lutte Contre le Cancer Provence-Alpes-Cĵte d'Azur, Marseille, France. tonnellec@marseille.fnclcc.fr

Leukemia & Lymphoma
|March 23, 2002
PubMed
Summary

Ikaros (Ik) protein isoforms are differentially expressed in leukemias, suggesting a role in cancer development. Further research is needed to determine if this deregulation causes or results from the disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fludarabine, cyclophosphamide and 2 Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patients.

Bone marrow transplantation·2026
Same author

Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French Experience.

Transplantation and cellular therapy·2026
Same author

[Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)].

Bulletin du cancer·2026
Same author

Clinical implementation of a one-step no-wash flow cytometry method allows for real-time monitoring of patients treated with autologous CAR-T cells.

Frontiers in oncology·2026
Same author

Equivalent CD34+ selection outcomes with CliniMACS prodigy and CliniMACS plus, enabling cryopreserved product processing.

Cytotherapy·2026
Same author

[Estimating the real price of CAR-T cells in France: From list price to net price].

Bulletin du cancer·2025

Area of Science:

  • Molecular Biology
  • Hematology
  • Cancer Research

Background:

  • Ikaros (Ik) protein, also known as LyF1, regulates genes in murine lymphoid cells.
  • Ikaros is crucial for hematopoietic stem cell differentiation, with gene inactivation causing lymphoid defects.
  • Alternative splicing generates multiple Ikaros isoforms with diverse functions, making it a model for post-transcriptional regulation studies.

Purpose of the Study:

  • To investigate the role of Ikaros isoforms in neoplastic processes.
  • To explore the hypothesis that Ikaros expression is deregulated in human leukemias.
  • To understand the potential involvement of post-transcriptional mechanisms in leukemia.

Main Methods:

  • Analysis of Ikaros isoform expression in different leukemia types.

Related Experiment Videos

  • Comparative studies of Ikaros expression patterns.
  • Review of existing literature on Ikaros and other human diseases with abnormal post-transcriptional regulation.

    • Main Results:

    • Evidence suggests varying expression of Ikaros isoforms across different leukemias.
    • A predominance of short Ikaros isoforms was observed in specific leukemia subsets.
    • Ikaros expression deregulation is hypothesized to occur in human leukemias.

    Conclusions:

    • Ikaros isoform expression is altered in leukemias, indicating potential involvement in the disease.
    • The precise role of Ikaros deregulation (cause or consequence) in leukemia remains to be elucidated.
    • Abnormal post-transcriptional regulation is a known factor in other human diseases, supporting further investigation in leukemia.